Klimax Working for the Climate: Through Humor, Play, and the Redefinition of Space

Por Robert Hamrén
Publicado em 2014-04-01

Mechanistic modelling of tesaglitazar pharmacokinetic data in subjects with various degrees of renal function – evidence of interconversion

Por Hamrén, Bengt, Ericsson, Hans, Samuelsson, Ola, Karlsson, Mats O
Publicado em 2008

Application of the integrated glucose–insulin model for cross‐study characterization of T2DM patients on metformin background treatment

Por Parkinson, Joanna, Hamrén, Bengt, Kjellsson, Maria C., Skrtic, Stanko
Publicado no Br J Clin Pharmacol (2016)

Model selection and averaging of nonlinear mixed-effect models for robust phase III dose selection

Por Aoki, Yasunori, Röshammar, Daniel, Hamrén, Bengt, Hooker, Andrew C.
Publicado no J Pharmacokinet Pharmacodyn (2017)

Pharmacokinetics of the Oral Selective CXCR2 Antagonist AZD5069: A Summary of Eight Phase I Studies in Healthy Volunteers

Por Cullberg, Marie, Arfvidsson, Cecilia, Larsson, Bengt, Malmgren, Anna, Mitchell, Patrick, Wählby Hamrén, Ulrika, Wray, Heather
Publicado no Drugs R D (2018)

Exposure–response for biomarkers of anticoagulant effects by the oral direct thrombin inhibitor AZD0837 in patients with atrial fibrillation

Por Lip, Gregory Y. H., Rasmussen, Lars H., Olsson, S. Bertil, Jensen, Eva, Hamrén, Bengt, Eriksson, Ulf G., Wåhlander, Karin
Publicado no Br J Clin Pharmacol (2015)

An enhanced-sensitivity branched-DNA assay for quantification of human immunodeficiency virus type 1 RNA in plasma.

Por Kern, D, Collins, M, Fultz, T, Detmer, J, Hamren, S, Peterkin, J J, Sheridan, P, Urdea, M, White, R, Yeghiazarian, T, Todd, J
Publicado em 1996

Efficacy and safety of AZD7594, an inhaled non-steroidal selective glucocorticoid receptor modulator, in patients with asthma: a phase 2a randomized, double blind, placebo-controll...

Por Mary N. Brown, Rainard Fuhr, Jutta Beier, Hong-Lin Su, Yingxue Chen, Henrik Forsman, Ulrika Wählby Hamrén, Helen Jackson, Ajay Aggarwal
Publicado em 2019-02-01

Navafenterol (AZD8871) in healthy volunteers: safety, tolerability and pharmacokinetics of multiple ascending doses of this novel inhaled, long-acting, dual-pharmacology bronchodil...

Por Victor Balaguer, Muna Albayaty, Eulalia Jimenez, Ulrika Wählby-Hamrén, Carol Astbury, Beatriz Seoane, Marie-Pierre Malice, Alejhandra Lei, Ajay Aggarwal, Ioannis Psallidas
Publicado em 2020-09-01

Biomarkers in Fasting Serum to Estimate Glucose Tolerance, Insulin Sensitivity, and Insulin Secretion

Por Goldfine, Allison B., Gerwien, Robert W., Kolberg, Janice A., O’Shea, Sheila, Hamren, Sarah, Hein, Glenn P., Xu, Xiaomei M., Patti, Mary Elizabeth
Publicado no Clin Chem (2010)

Associations of coffee consumption with markers of liver injury in the insulin resistance atherosclerosis study

Por Dickson, J. C., Liese, A. D., Lorenzo, C., Haffner, S. M., Watkins, S. M., Hamren, S. J., Stiles, J. K., Wagenknecht, L. E., Hanley, A. J.
Publicado no BMC Gastroenterol (2015)

Requirements for multi-level systems pharmacology models to reach end-usage: the case of type 2 diabetes

Por Nyman, Elin, Rozendaal, Yvonne J. W., Helmlinger, Gabriel, Hamrén, Bengt, Kjellsson, Maria C., Strålfors, Peter, van Riel, Natal A. W., Gennemark, Peter, Cedersund, Gunnar
Publicado no Interface Focus (2016)

Quantifying the release of biomarkers of myocardial necrosis from cardiac myocytes and intact myocardium

Por Marjot, Jack, Kaier, Thomas E, Martin, Eva D, Reji, Shiney S, Copeland, O’Neal, Iqbal, Mohammed, Goodson, Bob, Hamren, Sarah, Harding, Sian E, Marber, Michael S
Publicado no Clin Chem (2017)

Quantification of Human Immunodeficiency Virus Type 1 RNA Levels in Plasma by Using Small-Volume-Format Branched-DNA Assays

Por Yeghiazarian, Torange, Zhao, Yuqi, Read, Stanley E., Kabat, William, Li, Xiaoyi, Hamren, Sarah J., Sheridan, Patrick J., Wilber, Judith C., Chernoff, David N., Yogev, Ram
Publicado em 1998

A PET study comparing receptor occupancy by five selective cannabinoid 1 receptor antagonists in non-human primates

Por Hjorth, Stephan, Karlsson, Cecilia, Jucaite, Aurelija, Varnäs, Katarina, Hamrén, Ulrika Wählby, Johnström, Peter, Gulyás, Balázs, Donohue, Sean R, Pike, Victor W, Halldin, Christer, Farde, Lars
Publicado no Neuropharmacology (2015)

Development of a Type 2 Diabetes Risk Model From a Panel of Serum Biomarkers From the Inter99 Cohort

Por Kolberg, Janice A., Jørgensen, Torben, Gerwien, Robert W., Hamren, Sarah, McKenna, Michael P., Moler, Edward, Rowe, Michael W., Urdea, Mickey S., Xu, Xiaomei M., Hansen, Torben, Pedersen, Oluf, Borch-Johnsen, Knut
Publicado em 2009

Good Practices in Model‐Informed Drug Discovery and Development: Practice, Application, and Documentation

Por Marshall, SF, Burghaus, R, Cosson, V, Cheung, SYA, Chenel, M, DellaPasqua, O, Frey, N, Hamrén, B, Harnisch, L, Ivanow, F, Kerbusch, T, Lippert, J, Milligan, PA, Rohou, S, Staab, A, Steimer, JL, Tornøe, C, Visser, SAG
Publicado no CPT Pharmacometrics Syst Pharmacol (2016)